NYSE · Healthcare · Healthcare Plans

Humana Inc. (HUM)

As of Sep 25, 4:03 PM ET, Humana (HUM) last traded at $397.93, up 4.63% on the day. Its TickerHum research score is 49/100 (average). It reported revenue of $137.2B for the twelve months ending 2026-03-31, up 14.1% year over year, with a 1.8% operating margin.

Ratings

Reported fundamentals

MetricValuePeriod
Revenue$137.2BTTM ending 2026-03-31 · 10-Q
Revenue growth14.1%TTM ending 2026-03-31 · 10-Q
Net income$1.13BTTM ending 2026-03-31 · 10-Q
Diluted EPS$9.37TTM ending 2026-03-31 · 10-Q
Operating margin1.8%TTM ending 2026-03-31 · 10-Q
Net margin0.8%TTM ending 2026-03-31 · 10-Q
Free cash flow$1.27BTTM ending 2026-03-31 · 10-Q
Cash$4.95Bas of 2026-03-31 · 10-Q
Long-term debt$12.27Bas of 2026-03-31 · 10-Q
Debt / equity0.66as of 2026-03-31 · 10-Q

Source: SEC EDGAR XBRL company facts (CIK 0000049071).

Compare Humana with its closest competitors

Prices: Yahoo Finance (public) — Free public Yahoo Finance data. Prices may be delayed and are for information only.